Merck lifts full-year forecast as Keytruda sales soarBusiness, TherapeuticsMerck & Co. on Thursday reported better-than-expected third-quarter sales and profit on a jump in demand for blockbuster cancer immunotherapy Keytruda and human papillomavirus vaccine Gardasil. Read more October 27, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2021/09/Merck-begins-late-stage-trial-of-experimental-COVID-19-drug-Reuters-9-1-21.jpeg 182 277 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-10-27 10:36:332022-10-27 11:07:22Merck lifts full-year forecast as Keytruda sales soar
